Lataa...
A Pitfall of Treatment with Tosufloxacin for Pneumonia That Might Be Lung Tuberculosis
Tosufloxacin, which is not used to treat Mycobacterium tuberculosis, is a fluoroquinolone recommended for pneumonia when the possibility of tuberculosis infection cannot be excluded. In the present case, symptoms and chest infiltrative shadow initially improved by tosufloxacin. Therefore, we regarde...
Tallennettuna:
| Julkaisussa: | Intern Med |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Japanese Society of Internal Medicine
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6378169/ https://ncbi.nlm.nih.gov/pubmed/30643085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.1369-18 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|